Back to search

Institutional Repository of Vilnius University

Epigenetinių slopiklių poveikis histonų modifikacijoms ir genų raiškai genetiškai modifikuotose NK ląstelėse /

Abstract

dc:description

CAR-NK cell therapy is a promising adoptive cell therapy with a better safety profile than CAR-T therapy. However, its clinical use is still limited by poor cell persistence and proliferation in vivo, cell exhaustion in the tumor microenvironment, and insufficient cytotoxic activity. Epigenetic regulation may modulate CAR-NK cell function because DNA methylation, histone modifications, and gene expression changes are important for immune cell activity, differentiation, persistence, and antitumor response. In this study, the effects of the epigenetic inhibitors zebularine, BML-210, and EGCG on genetically modified CAR19-NK cells were investigated. After NK cells were modified with CAR19 construct and successful transduction was confirmed, the effects of these compounds on cell viability, DNA methylation, histone modifications, selected gene expression, and transcriptomic profile were evaluated. The selected concentrations of the inhibitors did not cause a strong decrease in CAR19-NK cell viability, which allowed their epigenetic effects to be assessed rather than direct cytotoxic effects. The results showed that epigenetic inhibitors affected the epigenetic state of CAR19-NK cells in different ways. Zebularine mainly affected DNA methylation by reducing global 5-methylcytosine levels and causing time dependent changes in DNMT gene expression. BML-210 was more related to the regulation of histone acetylation, changes in H3K9Ac levels, and enrichment of histone modifications linked to active transcription in the promoter regions of selected target genes. The effect of EGCG was less consistent and was more often associated with reduced H3K9Ac levels or H3K9Ac enrichment. Transcriptomic analysis showed that BML-210 caused broader gene expression changes than zebularine, especially in processes related to cell signalling, adhesion, interaction with the microenvironment, immune response, and chromatin regulation. In contrast, zebularine was more closely linked to DNA damage response, metabolism, and cellular stress pathways. In summary, the results show that epigenetic inhibitors can change the epigenetic and transcriptomic state of CAR19-NK cells, but their effects depend on the compound and are not uniform. The most noticeable positive changes were observed after BML-210 treatment, although a clear and consistent improvement of NK cell effector functions was not confirmed. Therefore, epigenetic modulation may be considered a promising additional strategy for regulating CAR19-NK cells, but its functional importance should be confirmed in further studies of cytotoxicity, activation, and cell persistence.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Daugėlaitė, Patricija,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Daugėlaitė, Patricija,. Epigenetinių slopiklių poveikis histonų modifikacijoms ir genų raiškai genetiškai modifikuotose NK ląstelėse /. Institutional Repository of Vilnius University, 2026. https://repository.vu.lt/VU:ELABAETD308330708&prefLang=en_US